Key facts: Iovance Reports $122M Q3 Revenue; 2027 AMTAGVI Lung Trial
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.